腹腔鏡検査機器の市場：タイプ、用途、エンドユーザー、地域別、2026～2032年

腹腔鏡検査機器市場の評価-2026～2032年

低侵襲手術手技への嗜好の高まり術後の痛みが少ない、回復時間が短い、傷跡が少ないなど様々なメリットがあるため、従来型開腹手術よりも腹腔鏡手術を選択する患者が増加しており、2023年には154億米ドルを超え、2032年には276億7,000万米ドルに達します。

さらに、高精細カメラやロボット支援手術機器などの技術革新により、腹腔鏡治療の精度と有効性が向上しています。さらに、肥満や胃腸障害などの慢性疾患の有病率の増加が腹腔鏡手術の需要を押し上げており、その結果、市場は継続的に拡大し、2026～2032年まで約8.39%のCAGRで成長すると予測されています。

腹腔鏡検査機器市場定義/概要

腹腔鏡検査機器は、低侵襲外科手術に使用される特殊な器具であり、外科医がカメラや様々な手術器具の助けを借りて小さな切開口から手術を行うことを可能にします。これらの器具の一般的な用途には、肥満手術、婦人科手術、泌尿器科手術、消化器外科手術などがあり、従来型開腹手術に比べて回復時間の短縮、術後の痛みの軽減、傷跡の最小化が可能になります。ロボット支援システム、強化された画像技術、人工知能の統合などの技術的進歩により、手術成績の向上や腹腔鏡下で行われる処置の範囲の拡大が期待され、腹腔鏡検査機器市場の将来は有望視されています。

慢性疾患の有病率上昇は腹腔鏡検査機器市場を促進するか？

慢性疾患の有病率の上昇は、腹腔鏡検査機器市場の成長を後押ししています。これらの疾患は、しばしば効果的な管理のための外科的介入を必要とするからです。肥満、糖尿病、胃腸障害などの慢性疾患は世界中でますます一般的になってきています。米国疾病予防管理センター（CDC）によると、米国では2021年に成人の約42.4％が肥満と分類され、腹腔鏡肥満手術の恩恵を受ける可能性のある人口が多いことが浮き彫りになりました。さらに、世界保健機関（WHO）は、消化器系疾患が世界の罹患率の主要原因の1つであると報告しており、腹腔鏡検査機器が促進する低侵襲外科手術の需要をさらに促進しています。

さらに、早期介入と予防ヘルスケアへのシフトは、腹腔鏡技術の採用を助長する環境を醸成しています。医療制度が費用対効果の高い治療と患者の予後改善を優先させる中、腹腔鏡手術は入院期間の短縮や回復時間の短縮など、関連する利点により支持を集めています。

規制課題は腹腔鏡検査機器市場の成長を妨げるか？

メーカーが地域によって異なるコンプライアンス要件の複雑な景観をナビゲートする必要があるため、規制状況は確かに腹腔鏡検査機器市場の成長を妨げる態勢を整えています。例えば米国では、食品医薬品局（FDA）が医療機器の承認を管理する厳しい規制を設けており、これが長くてコストのかかる承認プロセスにつながる可能性があります。この官僚的なハードルは、革新的な腹腔鏡技術の市場導入を遅らせ、メーカーが進化するヘルスケアニーズや市場の需要に迅速に対応する能力に影響を与える可能性があります。

さらに、臨床検査と膨大な文書化の要件は、中小企業の経営資源を圧迫し、より強固な規制戦略を持つ大企業と競争する能力を制限する可能性があります。さらに、世界各地の規制機関が患者の安全性と製品の有効性への注視を強めているため、メーカーは市販後の機器に対するモニタリングの強化に直面する可能性があります。その結果、製品のリコールや安全性警告の頻度が高まり、消費者の信頼に影響を与えるだけでなく、主要企業に経済的負担を強いることにもなりかねないです。

目次

第1章 腹腔鏡検査機器の世界市場導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 腹腔鏡検査機器の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 腹腔鏡検査機器の世界市場：タイプ別

• 概要
• 腹腔鏡
• エネルギー機器
• 鉗子
• アクセス機器

第6章 腹腔鏡検査機器の世界市場：用途別

• 概要
• 肥満手術
• 一般外科
• 婦人科手術
• 泌尿器外科

第7章 腹腔鏡検査機器の世界市場：エンドユーザー別

• 概要
• 病院
• 外来センター

第8章 腹腔鏡検査機器の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界の腹腔鏡検査機器市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第10章 企業プロファイル

• Karl Storz SE & Co
• Olympus Corporation
• Medtronic plc
• Braun Aesculap
• Stryker Corporation
• Richard Wolf GmbH
• Ethicon Inc.
• Smith & Nephew plc
• Cook Medical Incorporated
• ConMed Corporation
• Genesis MedTech
• Johnson & Johnson
• Boston Scientific Corporation
• Shenzen Midray Bio-medical Electronics Co. Ltd.
• Microline Surgical

第11章 付録

• 関連調査

Laparoscopy Devices Market Valuation - 2026-2032

The growing preference for minimally invasive surgical techniques. Patients are increasingly choosing laparoscopic operations over traditional open surgeries because they offer various benefits such as less postoperative pain, shorter recovery times, and less scarring is surpassing USD 15.4 Billion in 2023 and reaching USD 27.67 Billion by 2032.

Furthermore, technological breakthroughs such as high-definition cameras and robotic-assisted surgical devices are improving the precision and efficacy of laparoscopic treatments. Furthermore, the increased prevalence of chronic conditions such as obesity and gastrointestinal problems is driving up demand for laparoscopic procedures, resulting in continuous market expansion is expected to grow at a CAGR of 8.39% about from 2026 to 2032.

Laparoscopy Devices Market: Definition/ Overview

Laparoscopy devices are specialized instruments used in minimally invasive surgical procedures, enabling surgeons to perform operations through small incisions with the aid of a camera and various surgical tools. Common applications of these devices include bariatric surgery, gynecological procedures, urological surgeries, and gastrointestinal surgeries, allowing for reduced recovery times, less postoperative pain, and minimized scarring compared to traditional open surgery. The future of the Laparoscopy Devices Market looks promising, driven by technological advancements such as robotic-assisted systems, enhanced imaging technologies, and the integration of artificial intelligence, which are expected to improve surgical outcomes and broaden the range of procedures performed laparoscopically.

Will Rising Prevalence of Chronic Diseases is Propelling the Laparoscopy Devices Market?

The rising prevalence of chronic diseases is indeed propelling the growth of the Laparoscopy Devices Market, as these conditions often require surgical intervention for effective management. Chronic diseases such as obesity, diabetes, and gastrointestinal disorders are becoming increasingly common worldwide. According to the Centers for Disease Control and Prevention (CDC), approximately 42.4% of adults in the United States were classified as obese in 2021, highlighting a significant population that may benefit from laparoscopic bariatric surgery. Additionally, the World Health Organization (WHO) reports that digestive diseases are among the leading causes of morbidity globally, further driving the demand for minimally invasive surgical procedures that laparoscopic devices facilitate.

Furthermore, the shift towards early intervention and preventive healthcare is fostering an environment conducive to the adoption of laparoscopic techniques. As healthcare systems prioritize cost-effective treatments and improved patient outcomes, laparoscopic surgery has gained traction due to its associated benefits, such as shorter hospital stays and quicker recovery times.

Will Regulatory Challenges Hamper the Growth of the Laparoscopy Devices Market?

Regulatory challenges are indeed poised to hamper the growth of the Laparoscopy Devices Market, as manufacturers must navigate a complex landscape of compliance requirements that vary by region. In the United States, for example, the Food and Drug Administration (FDA) has stringent regulations governing the approval of medical devices, which can lead to lengthy and costly approval processes. This bureaucratic hurdle can delay the introduction of innovative laparoscopic technologies to the market, impacting the ability of manufacturers to respond swiftly to evolving healthcare needs and market demands.

Additionally, the requirement for clinical trials and extensive documentation can strain the resources of smaller companies, limiting their capacity to compete with larger firms that have more robust regulatory strategies. Moreover, as regulatory bodies worldwide intensify their focus on patient safety and product efficacy, manufacturers may face increased scrutiny of their devices post-market. This can lead to more frequent product recalls or safety alerts, which not only affect consumer trust but also impose financial burdens on companies.

Category-Wise Acumens

Will Increasing Adoption of Energy Devices Boost the Laparoscopy Devices Market?

The increasing adoption of energy devices in laparoscopic surgeries is set to significantly boost the laparoscopic devices market. Energy devices, such as electrosurgical generators and advanced ultrasonic devices, play a crucial role in enhancing surgical efficiency by providing precise control over tissue cutting and coagulation. These devices minimize the risk of thermal damage to surrounding tissues, resulting in fewer complications and improved patient outcomes.

As more healthcare facilities recognize the advantages of these technologies, the demand for energy devices in laparoscopic procedures is expected to rise, driving overall market growth. Moreover, the trend toward minimally invasive surgeries is further propelling the adoption of energy devices. Surgeons increasingly prefer these devices due to their ability to streamline surgical processes and reduce operating times.

The insufflators are the fastest growing segment, driven by the rising adoption of minimally invasive surgical techniques and the growing need for effective carbon dioxide delivery to create and maintain a pneumoperitoneum.

Will Widespread Availability of Bariatric Surgery Fuel the Laparoscopy Devices Market?

The widespread availability of bariatric surgery is set to significantly fuel the Laparoscopy Devices Market. As obesity rates continue to rise globally, with the World Health Organization reporting that over 1.9 billion adults were classified as overweight in 2021, the demand for effective weight-loss solutions, particularly surgical interventions, has increased. Laparoscopic bariatric procedures, such as gastric bypass and sleeve gastrectomy, are favored for their minimally invasive nature, leading to shorter recovery times, reduced postoperative pain, and fewer complications.

This growing acceptance and preference for bariatric surgery among both healthcare providers and patients are driving an increased demand for advanced laparoscopic devices, which are essential for performing these procedures effectively. Moreover, the healthcare industry's focus on improving patient outcomes and reducing healthcare costs is further propelling the growth of the Laparoscopy Devices Market. As more hospitals and surgical centers adopt laparoscopic techniques for bariatric surgeries, the need for specialized devices will continue to rise.

The Gynecological Surgery is the fastest-growing segment, driven by a rise in conditions such as endometriosis, fibroids, and infertility treatments that require laparoscopic interventions.

Country/Region-wise

Will the Technological Advancement in North America Drive the Expansion of The Laparoscopy Devices Market?

Technological advancements are poised to significantly drive the expansion of the Laparoscopy Devices Market in North America. Innovations such as enhanced imaging systems, robotic-assisted surgery, and advanced surgical instruments are making minimally invasive procedures more efficient and safer for patients. For instance, the adoption of robotic surgical systems, which saw a 15% increase in utilization rates across hospitals in 2023 according to the American College of Surgeons, is enhancing the precision of laparoscopic surgeries, thereby increasing the overall demand for these devices.

Additionally, the increasing prevalence of chronic diseases such as obesity and gastrointestinal disorders is driving the demand for laparoscopic surgeries, as these procedures offer shorter recovery times and fewer complications compared to traditional surgeries. The U.S. Centers for Disease Control and Prevention (CDC) reports that approximately 42.4% of adults in the United States were classified as obese in 2021, a statistic that underscores the need for effective surgical interventions.

Will Increasing Number of Well-Equipped Hospitals in Asia Pacific Propel the Laparoscopy Devices Market?

The increasing number of well-equipped hospitals in the Asia Pacific region is expected to significantly propel the Laparoscopy Devices Market. According to the World Health Organization (WHO), the number of hospitals in Asia has grown rapidly, with an increase of over 30% in the last decade, largely due to rising healthcare expenditures and investments in advanced medical technologies. This surge in healthcare infrastructure is accompanied by a growing emphasis on minimally invasive surgical procedures, as they offer benefits such as reduced recovery times and lower complication rates.

Furthermore, government initiatives aimed at improving healthcare accessibility and quality are driving this trend. For instance, the Indian government's National Health Policy aims to increase the number of surgical procedures conducted in hospitals, with a target of reaching a surgical volume of 13 million by 2025. This focus on expanding surgical capabilities, along with a reported 12% increase in the budget allocation for healthcare in countries like Indonesia and Malaysia, further underscores the region's commitment to enhancing healthcare services.

Competitive Landscape

The competitive landscape of the Laparoscopy Devices Market is characterized by a mix of established players and emerging startups, each focusing on innovative features such as real-time tracking, integration with IoT devices, and user-friendly interfaces. Companies are increasingly investing in research and development to enhance product offerings and improve customer service, creating a dynamic and rapidly evolving market environment.

Some of the prominent players operating in the Laparoscopy Devices Market include Karl Storz SE & Co, Olympus Corporation, Medtronic plc, Braun Aesculap, Stryker Corporation, Richard Wolf GmbH, Ethicon Inc., Smith & Nephew plc, Cook Medical Incorporated, ConMed Corporation, Genesis MedTech, Johnson & Johnson, Boston Scientific Corporation, Shenzen Midray Bio-medical Electronics Co. Ltd., Microline Surgical.

Latest Developments

• In August 2024 Medtronic announced the launch of its new HARMONIC(TM) PRIME ultrasonic scalpel, designed to improve precision and control during laparoscopic surgeries. This device integrates advanced technology to minimize thermal spread and enhance tissue preservation, aligning with the growing demand for minimally invasive surgical solutions.
• In July 2024 Johnson & Johnson completed its acquisition of Auris Health, a robotics company focused on advancing minimally invasive surgical techniques. This acquisition aims to strengthen Johnson & Johnson's position in the laparoscopic devices market by integrating robotics with laparoscopic technology, allowing for enhanced surgical capabilities and improved patient outcomes.
• In June 2024 Stryker introduced its IMPACT(TM) 3D Camera System, which provides enhanced visualization and depth perception for surgeons during laparoscopic procedures. This system features advanced imaging technology that aids in better identification of anatomical structures, improving surgical precision and patient safety.

Laparoscopy Devices Market, By Category

• Type
• Laparoscopes
• Energy Devices
• Insufflators
• Access Devices
• Application
• Bariatric Surgery
• General Surgery
• Gynecological Surgery
• Urological Surgery
• End-User
• Hospitals
• Ambulatory Centers
• Geography:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LAPAROSCOPY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL LAPAROSCOPY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL LAPAROSCOPY DEVICES MARKET, BY TYPE

• 5.1 Overview
• 5.2 Laparoscopes
• 5.3 Energy Devices
• 5.4 Insufflators
• 5.5 Access Devices

6 GLOBAL LAPAROSCOPY DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Bariatric Surgery
• 6.3 General Surgery
• 6.4 Gynecological Surgery
• 6.5 Urological Surgery

7 GLOBAL LAPAROSCOPY DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Centers

8 GLOBAL LAPAROSCOPY DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL LAPAROSCOPY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Karl Storz SE & Co
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Olympus Corporation
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Medtronic plc
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Braun Aesculap
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Stryker Corporation
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Richard Wolf GmbH
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Ethicon Inc.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Smith & Nephew plc
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Cook Medical Incorporated
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 ConMed Corporation
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments
• 10.11 Genesis MedTech
  • 10.11.1 Overview
  • 10.11.2 Financial Performance
  • 10.11.3 Product Outlook
  • 10.11.4 Key Developments
• 10.12 Johnson & Johnson
  • 10.12.1 Overview
  • 10.12.2 Financial Performance
  • 10.12.3 Product Outlook
  • 10.12.4 Key Developments
• 10.13 Boston Scientific Corporation
  • 10.13.1 Overview
  • 10.13.2 Financial Performance
  • 10.13.3 Product Outlook
  • 10.13.4 Key Developments
• 10.14 Shenzen Midray Bio-medical Electronics Co. Ltd.
  • 10.14.1 Overview
  • 10.14.2 Financial Performance
  • 10.14.3 Product Outlook
  • 10.14.4 Key Developments
• 10.15 Microline Surgical
  • 10.15.1 Overview
  • 10.15.2 Financial Performance
  • 10.15.3 Product Outlook
  • 10.15.4 Key Developments

11 Appendix

• 11.1 Related Research